The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...

Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...

Merck , known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the ...

Dr. Matthew Simmons, UPMC Western Maryland vice president of medical staff affairs, said vaccines provide the "single most powerful intervention" that have saved lives. He recently discussed the ...

What are the current CDC recommendations for vaccines? Here's the list from the government website as of Jan. 30, 2025.

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.

The ACIP-approved immunization schedules for children and adolescents and for adults for 2025 have been published.

Vaccination rates for shots that prevent diseases like polio, measles and others have fallen dramatically for some of the ...

children, and adolescents aged 6 weeks to under 17 years. The trial will compare immunogenicity and safety with existing approved pneumococcal vaccines after up to 4 doses. SK bioscience and Sanofi ...

which will help reduce the burden of pneumococcal diseases, offering greater protection for vulnerable populations, including children and the elderly. PAHO says that together with the government of ...

HealthDay News — The Advisory Committee on Immunization Practices (ACIP)-approved immunization schedules for children and adolescents and for adults for 2025 have been published in the Jan. 16 issue ...

(HealthDay News) — The Advisory Committee on Immunization Practices (ACIP)-approved immunization schedules for children and adolescents ... Centers for Disease Control and Prevention Morbidity ...